blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3532091

EP3532091 - ANTI-MIC ANTIBIDIES AND METHODS OF USE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.02.2022
Database last updated on 07.10.2024
FormerExamination is in progress
Status updated on  15.04.2021
FormerRequest for examination was made
Status updated on  02.08.2019
FormerThe international publication has been made
Status updated on  05.05.2018
Formerunknown
Status updated on  29.11.2017
Most recent event   Tooltip18.02.2022Application deemed to be withdrawnpublished on 23.03.2022  [2022/12]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2019/36]
Inventor(s)01 / LOMBANA, Twyla, Noelle
c/o Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
02 / SPIESS, Christoph
c/o Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
03 / KIM, Jeong
c/o Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
04 / TOY, Evangeline
c/o Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
05 / YE, Zhengmao
c/o Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
06 / BEVERS, III, Jack
c/o Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
07 / SCHARTNER, Jill
c/o Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
08 / COOK, Ryan
c/o Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
09 / MATSUMOTO, Marissa
c/o Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
10 / BERKLEY, Amy
c/o Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
 [2019/36]
Representative(s)Brodbeck, Michel
F. Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[2019/36]
Application number, filing date17801172.227.10.2017
[2019/36]
WO2017US58880
Priority number, dateUS201662414670P29.10.2016         Original published format: US 201662414670 P
[2019/36]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2018081648
Date:03.05.2018
Language:EN
[2018/18]
Type: A2 Application without search report 
No.:EP3532091
Date:04.09.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 03.05.2018 takes the place of the publication of the European patent application.
[2019/36]
Search report(s)International search report - published on:EP10.01.2019
ClassificationIPC:A61K39/00, C07K16/00, C07K16/08, C07K16/28
[2019/36]
CPC:
C07K16/2833 (EP,US); A61K47/6849 (US); A61P35/00 (EP,US);
A61P35/02 (EP); C07K16/08 (EP); A61K2039/505 (EP,US);
C07K2317/24 (EP,US); C07K2317/34 (EP,US); C07K2317/41 (US);
C07K2317/55 (EP,US); C07K2317/56 (US); C07K2317/567 (US);
C07K2317/76 (EP,US); C07K2317/92 (US); C07K2317/94 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/36]
TitleGerman:ANTI-MIC-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG[2019/36]
English:ANTI-MIC ANTIBIDIES AND METHODS OF USE[2019/36]
French:ANTICORPS ANTI-MIC ET MÉTHODES D'UTILISATION[2019/36]
Entry into regional phase29.05.2019National basic fee paid 
10.07.2019Designation fee(s) paid 
10.07.2019Examination fee paid 
Examination procedure10.07.2019Examination requested  [2019/36]
10.07.2019Date on which the examining division has become responsible
19.05.2020Amendment by applicant (claims and/or description)
14.04.2021Despatch of a communication from the examining division (Time limit: M06)
26.10.2021Application deemed to be withdrawn, date of legal effect  [2022/12]
17.11.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2022/12]
Divisional application(s)EP21200503.7
Request for further processing for:19.05.2020Request for further processing filed
19.05.2020Full payment received (date of receipt of payment)
Request granted
02.06.2020Decision despatched
Fees paidRenewal fee
11.10.2019Renewal fee patent year 03
09.10.2020Renewal fee patent year 04
08.10.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]WO2013117647  (INNATE PHARMA [FR]);
 [XI]WO2014144791  (DANA FARBER CANCER INST INC [US]);
 [XI]WO2014140904  (NOVELOGICS BIOTECHNOLOGY INC [CA]);
 [XI]WO2015085210  (DANA FARBER CANCER INST INC [US]);
 [XI]WO2016154585  (SENTMAN CHARLES [US], et al);
 [T]WO2017157895  (INNATE PHARMA [FR]);
by applicantUS4676980
 US4737456
 US4816567
 US4943533
 EP0404097
 WO9301161
 US5208020
 WO9308829
 US5212290
 WO9316185
 WO9411026
 WO9429351
 US5416064
 EP0659439
 US5457105
 US5475001
 WO9603397
 US5500362
 EP0425235
 WO9630347
 WO9633978
 WO9633980
 US5571894
 WO9640210
 US5587458
 US5616582
 US5624821
 US5635483
 US5648260
 US5648237
 US5654307
 WO9730087
 US5679683
 WO9738983
 US5712374
 US5714586
 US5731168
 WO9814451
 US5739116
 US5747498
 US5750373
 US5760041
 US5767285
 US5770599
 US5770429
 US5770701
 US5770710
 US5773001
 US5780588
 US5789199
 US5804396
 WO9843960
 US5821337
 WO9850433
 WO9850038
 US5840523
 WO9858964
 US5866572
 US5869046
 WO9906378
 WO9906396
 WO9909016
 US5877296
 US5891996
 WO9922764
 WO9924037
 US5959177
 WO9951642
 US6002008
 US6040498
 US6075181
 US6084095
 WO0061739
 US6140332
 US6150584
 US6171586
 US6194551
 WO0129246
 US6235883
 US6248516
 US6265410
 US6267958
 US6344459
 US6344455
 WO0231140
 US6391874
 US6399602
 US6417429
 US6420548
 US6455534
 US2002164328
 WO03011878
 US6521620
 US2003115614
 US6596726
 US6602863
 US6602684
 US2003157108
 US6630579
 WO03085119
 WO03084570
 WO03085107
 US6713484
 US2004093621
 US6737056
 US2004110704
 US2004110282
 US2004109865
 US2004132140
 WO2004056312
 US2005014934
 US2005079574
 WO2005035586
 WO2005035778
 US2005119455
 US2005123546
 WO2005053742
 WO2005100402
 US2005260186
 US2005266000
 US6982321
 US2006025576
 WO2006029879
 WO2006044908
 US7041870
 US2006104968
 US7087409
 US7125978
 WO2006121168
 WO2007005874
 US7189826
 US2007061900
 US2007117126
 US2007160598
 US2007237764
 US2007292936
 US7332581
 US2008069820
 US7371826
 WO2008077546
 US2009002360
 US7498298
 US7521541
 US7527791
 WO2009089004
 WO2009101611
 WO2009114335
 WO2010005958
 WO2010027827
 WO2010077634
 WO2011066342
 WO2013117647
 WO2015085210
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.